Plasma pTau181 and Amyloid Markers Predict Conversion to Dementia in Idiopathic RBD

NAPS members from McGill University, led by NAPS Co-Principal Investigator, Ron Postuma, have published a groundbreaking study in Brain journal! 🧠💡

The team found that blood markers of Alzheimer's Disease, including the Aβ42/40 ratio and pTau181, could help predict who is at risk of developing dementia with Lewy bodies (DLB) in the future. This important discovery highlights the need to consider multiple disease processes occurring simultaneously in the brain.

NAPS is actively working on similar studies with our participants, advancing the field of neurodegenerative research. Read more at the link below and stay tuned for more updates!